[Study on effect of promoting blood circulation drugs components in treating unstable angina in patients with blood stasis inflammatory levels].
OBJECTIVE
To discussion the effects of Huoxue components of effective drug in treating unstable angina in patients with blood stasis WBC (WBC), C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-alpha).


METHODS
one hundred and twenty cases of unstable angina were randomly divided into the conventional therapy group, component compatibility group, Pieces group and Xuesaitong group 4 groups, each with 30 cases. Observation of patients before and after treatment of clinical efficacy, blood lipid indicators and the indicators changes.


RESULTS
Component compatibility group after treatment clinical marked improvement in conditions, and the WBC, CRP, IL-6 and TNF-alpha, TC, TG levels lower than before treatment, there were significant differences (P < 0.05), and lower than the other three groups After treatment (P < 0.05). And HDL-C after treatment than before treatment increased, there were significant differences (P < 0. 05).


CONCLUSIONS
Huoxue-effective component compatibility can be effective treatment of unstable angina blood stasis, and could inhibit the inflammatory level.
Liu
Xian
X
Guang'anmen Hospital, China Academy of Chinese Medicinal Sciences, Beijing 100053, China.
Li
Ji
J
Yang
Ge
G
Wang
Jie
J
D000368:Aged; D000789:Angina, Unstable / Q000097:blood / Q000188:drug therapy* / Q000276:immunology*; D001775:Blood Circulation / Q000187:drug effects*; D002097:C-Reactive Protein / Q000276:immunology; D002316:Cardiotonic Agents / Q000008:administration & dosage*; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000097:blood / Q000276:immunology; D007962:Leukocytes / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000097:blood / Q000276:immunology
D002316:Cardiotonic Agents; D004365:Drugs, Chinese Herbal; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D002097:C-Reactive Protein